Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
McGill, industry, CQDM and Brain Canada collaborate for drug discovery
Details : The funding aims to advance the discovery of investigational products that have made significant progress in development and could help treat insomnia and neuropathic pain.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
July 03, 2024
LOOKING FOR A SUPPLIER?